“…Among these, the keto form is the main fraction (about 90%) and is responsible for the pharmacological features of this bioactive agent (Ahmad et al, 2019; Darakhshan et al, 2015). TQ has proven to possess anti‐inflammatory (Shaterzadeh‐Yazdi et al, 2018), anti‐microbial (Khan, 2018; Perera et al, 2021), anti‐histaminic, hypolipidemic (Ahmad & Beg, 2013b), and antioxidant properties (Cobourne‐Duval et al, 2016; Guan et al, 2018; Zeinvand‐Lorestani et al, 2018) that could be of effective therapeutic effects in the prevention/treatment of different diseases such as diabetes (El‐Aarag et al, 2017; Farkhondeh et al, 2017), various cancers (Almatroodi et al, 2020; Imran et al, 2018; Junaid et al, 2021; Mahmoud & Abdelrazek, 2019; Majdalawieh et al, 2017), cardiovascular disorders (Ahmad & Beg, 2013a; Xu et al, 2018), and neurodegenerative disease (Farkhondeh et al, 2018; Samarghandian et al, 2018).…”